Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Horwitz

Showing results (61-70 of 208) with videos related to

Pageof 21
Sort By:
Leukemia & Lymphoma|April 18, 2009
A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patientsAdrienne A Phillips, Robert D Willim, David G Savage, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2012
Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experienceMartin H Voss, Matthew A Lunning, Jocelyn C Maragulia, et al.
European Journal of Haematology|March 27, 2023
Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposureMichael J Buege, Esther Drill, Steven M Horwitz, et al.
The Breast Journal|December 7, 2018
Breast implant-associated anaplastic large cell lymphoma: Clinical and imaging findings at a large US cancer centerBrittany Z Dashevsky, Katherine M Gallagher, Anne Grabenstetter, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective studyMichael A Marchetti, Melissa P Pulitzer, Patricia L Myskowski, et al.
Genes, Chromosomes & Cancer|August 12, 2024
A Novel JAK2 Fusion in T-Cell Prolymphocytic LeukemiaOzgur Can Eren, Robert Stuver, Ting Zhou, et al.
Blood Cancer Journal|March 8, 2020
Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphomaMariko Yabe, Qi Gao, Neval Ozkaya, et al.
Cytometry. Part B, Clinical Cytometry|April 22, 2022
PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndromeNatasha E Lewis, Qi Gao, Kseniya Petrova-Drus, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomesRobert Stuver, Stephen Dusza, Zachary D Epstein-Peterson, et al.
Blood Advances|April 20, 2018
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphomaAnita Kumar, Santosha Vardhana, Alison J Moskowitz, et al.
Pageof 21

Showing results (61-70 of 208) with videos related to

Sort By:
Pageof 21
Leukemia & Lymphoma|April 18, 2009
A multi-institutional experience of autologous stem cell transplantation in North American patients with human T-cell lymphotropic virus type-1 adult T-cell leukemia/lymphoma suggests ineffective salvage of relapsed patientsAdrienne A Phillips, Robert D Willim, David G Savage, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2012
Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experienceMartin H Voss, Matthew A Lunning, Jocelyn C Maragulia, et al.
European Journal of Haematology|March 27, 2023
Low incidence of cardiotoxicity in patients with non-Hodgkin lymphoma receiving EPOCH after prior anthracycline exposureMichael J Buege, Esther Drill, Steven M Horwitz, et al.
The Breast Journal|December 7, 2018
Breast implant-associated anaplastic large cell lymphoma: Clinical and imaging findings at a large US cancer centerBrittany Z Dashevsky, Katherine M Gallagher, Anne Grabenstetter, et al.
Journal of the American Academy of Dermatology|December 3, 2014
Cutaneous manifestations of human T-cell lymphotrophic virus type-1-associated adult T-cell leukemia/lymphoma: a single-center, retrospective studyMichael A Marchetti, Melissa P Pulitzer, Patricia L Myskowski, et al.
Genes, Chromosomes & Cancer|August 12, 2024
A Novel JAK2 Fusion in T-Cell Prolymphocytic LeukemiaOzgur Can Eren, Robert Stuver, Ting Zhou, et al.
Blood Cancer Journal|March 8, 2020
Bright PD-1 expression by flow cytometry is a powerful tool for diagnosis and monitoring of angioimmunoblastic T-cell lymphomaMariko Yabe, Qi Gao, Neval Ozkaya, et al.
Cytometry. Part B, Clinical Cytometry|April 22, 2022
PD-1 improves accurate detection of Sezary cells by flow cytometry in peripheral blood in mycosis fungoides/Sezary syndromeNatasha E Lewis, Qi Gao, Kseniya Petrova-Drus, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|May 31, 2024
Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomesRobert Stuver, Stephen Dusza, Zachary D Epstein-Peterson, et al.
Blood Advances|April 20, 2018
Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphomaAnita Kumar, Santosha Vardhana, Alison J Moskowitz, et al.
Pageof 21